CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress
Provides interested parties the ability to ask questions and submit topics for future videos
Access the AIM CEO Corner Here!
“Keeping our stakeholders well informed is absolutely essential to the future success of AIM ImmunoTech,” states Equels. “CEO Corner is a new way for us to connect directly with both current and potential stockholders. CEO Corner segments will provide expanded perspective on press releases, clinical trials and other corporate advancements as we continue to push forward with our development pipeline. We believe in the future of Ampligen and are dedicated to growing value for all stakeholders.”
The CEO Corner is now accessible on the Company’s website here.
About
For more information, please visit aimimmuno.com and connect with the Company on Twitter, LinkedIn, and Facebook.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bf36df6a-66a3-4b6b-9b53-57c074b48a66
Investor Contact:JTC Team, LLC Jenene Thomas (833) 475-8247 AIM@jtcir.com
AIM CEO Corner
AIM CEO Corner
2024 GlobeNewswire, Inc., source